clotrimazole for oral thrush, and neomycin to sterilize the gut. The macular rash continued for the next few days, but general condition-remained satisfactory. 9.9.72: further dose of methotrexate 10.9.72: clotrimazole stopped and amphotericin B given instead.
On 19.9.72 (three weeks after the graft) eosinophils were 37%, reticulocytes 4.6%, suggesting 'good take of graft'. On 21.9.72 the stools were formed and he gained weight; on the same day (one month after graft) he suddenly became jaundiced, with pale stools and dark urine, but appeared generally well. Bilirubin 5.0 mg/100 ml, alkaline phosphatase 90 K-A units, SGOT 1000 iu. IgG now 510 (initially<200 ), IgA 110 (<30), IgM 185 (<15) mg/100 ml. On 4.10.74 Australia antigen in both father and son were negative. Tests showed only a slight degree of C3 conversion. He remained jaundiced and liver and spleen became palpable. Discharged on 1.11.72 (two months after graft), although liver and spleen remained enlarged. Lymphocyte transformation 40 % of normal. 21.3.73: at routine outpatient appointments his parents drew attention to yellow streaks on his hands, clinically resembling xanthomata (Fig 3) . Total cholesterol 13.52 mg/100 ml. He was thought to have hyperlipoproteinmmia, class B (Dr J P Billimoria) and was given cholestyramine chloride. Liver biopsy (Dr Roger Williams) showed slight dilatation of biliary tract and an inflammatory infiltrate of lymphocytes and polymorphs, consistent with mild hepatitis.
Fig 3 Case 3 Xanthomata following bone marrow transplant
He has kept well and the only abnormal physical sign is a palpable firm spleen. On 8.10.74 total cholesterol was 125 mg/100 ml. On 14.11.74 lymphocyte transformation showed a low but normal response to PHA, normal responses to candida immunogen and pooled lymphocytes, no response to father's lymphocytes. On 19.11.74 immunoglobulin estimations showed: IgG 975, IgA 486, IgM 673, IgD 75 mg/100 ml, and IgE 37 iu/ml. T lymphocytes with sheep red blood cells rosetting 1234/mm3 (normal 470-1800), 'unmarked lymphocytes' 470 (a normal result). His weight is on the 75th percentile and his height on the 50th; he appears well.
These encouraging results are associated with a considerable amount of specialized therapy, before and after transplants, and would have been impossible without the skill and devotion of house physicians, registrars and nursing staff. 
Role of Thymus Grafting in Treatment of Immunodeficiency
In 1960 at a symposium (Ciba 1960) of worldrenowned immunologists, no particular mention was made of the thymus, and they were reluctant to accept its role in immunity. Within a year, Miller (1961) discovered that thymectomized mice died of infection and a wasting disease. By placing the thymus in a millipore filter in the subcutaneous tissue of the mouse, partial reconstitution of the immune defect was effected (Osoba & Miller 1963) . Elders et al. (1968) Section ofPadiatrics reported that if a thymectomized mouse could be rendered pregnant, the wasting disease halted, but for only as long as the pregnancy continued. After parturition, wasting and infections again became evident and examination of the offspring revealed grossly enlarged thymus glands.
It is now generally accepted that there are two populations of lymphocytes, both derived from a common stem cell. In avian species some lymphocytes, having been acted on by the bursa of Fabricius, are capable of producing circulating immunoglobulins; other lymphocytes, having been acted upon by the thymus gland, are responsible for cell-mediated immunity. The site where the lymphocytes are processed to produce immunoglobulins is not yet known in man; but that thymus-derived lymphocytes are required for cell mediated immunity (CMI) is now well established (Coombs 1974) . Thymus-derived (T) lymphocytes manifest their effects clinically by delayed hypersensitivity and allograft rejection. T lymphocyte function can be measured rapidly in the laboratory on small quantities of blood by lymphocyte transformation to blasts in response to candida antigen (Foroozanfar et al. 1974 ), phytohoemaglutinin (PHA) (Yamamura 1973) and mixed lymphocyte cultures. T lymphocytes can be identified by their capability to form rosettes with sheep red blood cells (SRBC) as originally described by Coombs et al. (1970) .
Though an association between convulsions and absence of the thymus gland had been reported in 1828 (Harrington 1828) , Di George (1965) described his syndrome of congenital defects of the third and fourth pharyngeal pouches with abnormalities of the ear, jaw and major blood vessels, with thyroid and parathyroid deficiencies in addition to absent thymus glands. These children tend to die of infections and some have variable immunological deficiencies; the above mentioned tests being used to reveal any deficiency of T lymphocyte function. Two grgMps of workers simultaneously described successful correction of the defect in cellmediated immunity in cases of this syndrome by means of fetal thymus transplants (August et al. 1968 , Cleveland et al. 1968 ). These children became immunologically competent, their other endocrine problems being managed with replacement therapy.
The patient reported by Cleveland et al. (1968) is said to be well six years later, but of course still has his physical defects.
In both these cases the patient was a boy and the thymus was from a female fetus, one of 13 weeks and the other of 16 weeks gestation. Both grafts were implanted as fragments within the rectus sheath. In neither case was there any graft versus host reaction (GVHR) and although their immune processes were completely reconstituted within days or weeks, no female (i.e. donor) lymphocytes could be found, either then or at any time later. So in some way the implanted thymus had 'switched on' the recipient's own lymphocytes. It seems that implantation of the donor thymus in fragments is a more effective method than injection of dispersed, though not homogenized, thymus tissue (Levy et al. 1971) . A potential danger is a GHVR but this can be forestalled by prior irradiation of the thymus without impairing the efficacy of the graft.
There are many conditions in which T cell deficiency occurs, the most notable being combined immune deficiency (CID). Many reports are available of the treatment of this with only a bone marrow graft (Gatti et al. 1968 , Rubenstein et al. 1971 , Yamamura et al. 1972 ) but if associated with complete thymic aplasia, and not just disuse atrophy of the thymus as a secondary phenomenon, then thymic transplant would also be required to completely restore immunity. It is certainly true that in some cases of CID a radiologically visible thymus shadow appears after bone marrow grafting. CID has also been treated by thymus transplant alone. A successful case, reported by Ammann et al. (1973) , is a good example but certain points are of particular interest: (1) Graft versus host reaction occurred.
(2) It was four months after the implant before any evidence of CMI could be detected, and this took nine months to reach normal levels. It is known in the neonate that it takes nine to twelve months for the T cells to fully mature (Matsaniotis et al. 1974) . (3) The circulating active lymphocytes were shown to be of donor origin. (4) No evidence of humoral immunity had appeared by eighteen months, and the patients still required gamma-globulin replacement therapy. Radl et al. (1972) reported a patient with CID who received both a bone marrow graft from his histocompatible sister and a fetal thymus graft. This boy has developed both humoral and cellular immunity but his T lymphocytes are of donor origin. Nezelof et al. (1964) described a group of T-cell-deficient patients, but it would seem that the more modern classification as recommended by WHO (New EnglandJournal ofMedicine 1973) or Hobbs (1974) would break this original group into a number of different syndromes.
Chronic mucocutaneous candidiasis (CMC) may be associated with variable immunological defects. Levy et al. (1971) described a boy aged 17 with CMC and impaired T cell function. He had not responded to transfer factor but responded promptly by both laboratory and clinical criteria to two fetal thymus transplants. A series of patients with ataxia-telangiectasia has been reported from Moscow (Lopukhin et al. 1973) where transplants of the thymus and sternum from very early neonatal deaths have been used in an attempt to correct both the T cell and the IgA deficiency. Good neurological as well as immunological results are claimed. No successful thymus transplants in the Wiskott-Aldrich syndrome have been reported but if treated with transfer factor i.e. a dialysable leukocyte extract, then clinical improvement is correlated with improvement in rosette-forming capabilities of the T cells (Wybran et al. 1972) . A recent paper from the Hammersmith Hospital (Valdimarsson et al. 1974 ) describes a girl with eczema, recurrent ulceration and T cell deficit who is being treated successfully with a dialysable leukocyte extract. Secondary T cell deficits and depressions of function are relatively common and are well recognized, some causes being: maternal factors against T cells; congenital rubella; viral infection; lepromatous leprosy; Hodgkin's disease; lymphomata; T lymphocyte leukemia; malnutrition; iatrogenic factorsradiation, antilymphocyte globulin, vinca group drugs, corticosteroids; walnuts.
A 6-year-old boy (see Foroozanfar et al. 1975 ) had a pure and considerable T cell deficit. No other abnormalities, either anatomical or immunological, were present. He had repeated episodes of pneumonia and was missing threequarters of his schooling. A thymus graft resulted in normal T cell function forty-eight hours after the graft; tests were again normal eighteen months later. A smallpox vaccination, performed two months after the graft, gave a normal primary response. His school attendance improved considerably.
Professor J G Humble and Dr A J Barrett (Westminster Hospital, London SWI)
Technique of Bone Marrow Transplantation
From 1971 to December 1974 6 cases of primary immune deficiency have been treated by bone marrow transplantation at Westminster Hospital. They comprised 3 cases of severe combined immune deficiency (SCID), two cases of congenital hypogammaglobulinemia (CHGA) and one case ofchronic granulomatous disease (CGD). Five of the cases were under the clinical care of Dr I M Anderson. The remaining one, the case of CGD, was under the care of Dr K Hugh-Jones. Tests defining the immune status of the patients were carried out in Professor J R Hobbs's laboratory and the essential blood grouping and tissue typing of the families, the recipient and the donors, were performed in Dr D C 0 James's Department of Blood Transfusion and Tissue Typing.
The lymphocytes of the chosen donor were then tested against the lymphocytes of the recipient by the 'two way' mixed lymphocyte reaction (MLR). If the results of the MLR showed no significant reaction of donor against recipient or recipient against donor then the clinical status of the donor was carefully evaluated. The donor was assessed most critically by clinical examination with urine testing, chest X-ray and ECG examination. Blood counts, Australia antigen tests and other relevant blood tests were also performed. The donor was always under the care of a consultant not attached to the transplant team. The axiom 'Donors are not patients' was always at the forefront of everybody's mind.
The method for taking bone marrow cells was essentially that of Pegg (1966) , which has
